Joint Pain
Results of new research suggests there is wide-ranging confusion amongst consumers about which is the most appropriate OTC painkiller for joint pain. Clearer packaging may therefore mean that millions in the UK could better self-manage their pain.
The survey confirms Anadin’s belief that there needs to be more explicit labelling around joint painkillers.
The vast majority (85%) of those interviewed felt that painkillers for joint pain were poorly labelled and a staggering 93% want packaging to be clearer.
It is estimated that nine million people in the UK suffer from painful joints. It can affect people of all ages and includes conditions such as joint injuries caused by hard physical activity3.
The new painkiller contains ibuprofen, which is particularly effective for the relief of joint pain as it acts both to reduce the pain, and the swelling around the joints that causes this pain.
Joint pain can have a significant impact on everyday life. Previous research around joint pain has shown that over a third (37%) of those surveyed suffer from tiredness as a symptom of joint pain.
This week Anadin launched a new, long-lasting analgesic called Anadin Joint Pain, which can last up to eight hours.
This product will go some way to making it easier for consumers to find a relevant oral joint pain treatment in shops.
This new treatment has been specially designed to help people deal with joint pain it can last for up to eight hours, allowing them to take two tablets to help them sleep right through the night or get through the working day.
Its up to eight hour effect also means that fewer additional forms of pain relief may be sought having to take too many tablets is a key problem for many consumers with 54%4 expressing a desire to take fewer tablets to achieve the same effect for their joint pain.